Back to Peptide Database
ImmuneResearch Phase

Beta-Defensin 2

Overview

Beta-defensin 2 (hBD-2) is an antimicrobial peptide of approximately 40 amino acids produced by epithelial cells in response to infection or inflammation. It disrupts microbial membranes and also functions as a chemoattractant for immune cells via CCR6 receptor binding. Therapeutic interest includes infection control and immune adjuvant applications.

Key Research Findings

Preclinical studies have confirmed broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses, along with immunomodulatory properties. Clinical development of recombinant or synthetic beta-defensin 2 for topical or systemic use remains in early phases, with no advanced trials or approvals reported.

Route of Administration

Topical, Subcutaneous injection

Regulatory Status

Research Phase

Interested in Beta-Defensin 2?

Find a verified provider experienced with Beta-Defensin 2 protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Beta-Defensin 2 Provider

Related Peptides

Thymalin

Investigational

A peptide bioregulator originally extracted from bovine thymus gland, consisting of a mixture of polypeptides that modulate immune function. Thymalin restores T-cell mediated immunity by promoting T-lymphocyte maturation and differentiation in the thymus. It also normalizes the ratio of T-helper to T-suppressor cells and enhances phagocytic activity of neutrophils and macrophages.

LL-37

Research Phase

The only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide cleaved from the precursor protein hCAP18. LL-37 disrupts microbial membranes through electrostatic interactions and exerts broad-spectrum activity against bacteria, fungi, and enveloped viruses. Beyond direct antimicrobial effects, it modulates innate immunity by recruiting immune cells, promoting angiogenesis, and regulating inflammatory cytokine release.

VIP (Vasoactive Intestinal Peptide)

Investigational

A 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems and immune cells. VIP acts through VPAC1 and VPAC2 receptors to produce potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-12) and promoting regulatory T-cell differentiation. It also functions as a vasodilator, bronchodilator, and neuromodulator.

Thymosin Alpha 1 (Zadaxin)

Investigational

A 28-amino acid peptide originally isolated from thymic tissue (thymosin fraction 5) that serves as a potent immunomodulator. Thymosin alpha 1 enhances T-cell maturation, dendritic cell function, and antibody responses by activating Toll-like receptors (TLR2, TLR9) on innate immune cells. It promotes Th1 immune responses and augments vaccine efficacy while modulating inflammatory cytokine production.